Page last updated: 2024-11-02

pioglitazone and Leukoplakia, Oral

pioglitazone has been researched along with Leukoplakia, Oral in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Leukoplakia, Oral: A white patch seen on the oral mucosa. It is considered a premalignant condition and is often tobacco-induced. When evidence of Epstein-Barr virus is present, the condition is called hairy leukoplakia (LEUKOPLAKIA, HAIRY).

Research Excerpts

ExcerptRelevanceReference
"Oral leukoplakia is defined as a mucous membrane disorder characterized by white patches that cannot be scraped off."1.48PPARĪ³-Mediated p21 Induction in Aerodigestive Preneoplastic Cell Lines. ( Miller, WA; Ondrey, FG; Wuertz, BR, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miller, WA1
Wuertz, BR1
Ondrey, FG1

Other Studies

1 other study available for pioglitazone and Leukoplakia, Oral

ArticleYear
PPARĪ³-Mediated p21 Induction in Aerodigestive Preneoplastic Cell Lines.
    The Annals of otology, rhinology, and laryngology, 2018, Volume: 127, Issue:10

    Topics: Apoptosis; Blotting, Western; Cell Division; Cell Line, Tumor; Cell Proliferation; Gene Expression R

2018